AUTHOR=Gill Tejpal , Stauffer Patrick , Asquith Mark , Laderas Ted , Martin Tammy M. , Davin Sean , Schleisman Matthew , Ramirez Claire , Ogle Kimberly , Lindquist Ingrid , Nguyen Justine , Planck Stephen R. , Shaut Carley , Diamond Sarah , Rosenbaum James T. , Karstens Lisa TITLE=Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota JOURNAL=Frontiers in Immunology VOLUME=13 YEAR=2022 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.965634 DOI=10.3389/fimmu.2022.965634 ISSN=1664-3224 ABSTRACT=
Axial spondyloarthritis (axSpA) is an inflammatory arthritis involving the spine and the sacroiliac joint with extra-articular manifestations in the eye, gut, and skin. The intestinal microbiota has been implicated as a central environmental component in the pathogenesis of various types of spondyloarthritis including axSpA. Additionally, alterations in the oral microbiota have been shown in various rheumatological conditions, such as rheumatoid arthritis (RA). Therefore, the aim of this study was to investigate whether axSpA patients have an altered immunoglobulin A (IgA) response in the gut and oral microbial communities. We performed 16S rRNA gene (16S) sequencing on IgA positive (IgA+) and IgA negative (IgA-) fractions (IgA-SEQ) from feces (n=17 axSpA; n=14 healthy) and saliva (n=14 axSpA; n=12 healthy), as well as on IgA-unsorted fecal and salivary samples. PICRUSt2 was used to predict microbial metabolic potential in axSpA patients and healthy controls (HCs). IgA-SEQ analyses revealed enrichment of several microbes in the fecal (